pharmaceutical daily

July 23, 2019 Off

PCSK9is shown to lower improve cardiovascular outcomes, many rejected by their insurance plan

New research from the FH Foundation highlights that individuals at high risk for cardiovascular events, including those with familial hypercholesterolemia (FH) or atherosclerotic cardiovascular disease (ASCVD), experienced more heart attacks, strokes and other cardiovascular events when they were unable to obtain their prescribed PCSK9 inhibitor (PCSK9i), a cholesterol-lowering treatment.

July 23, 2019 Off

Advaxis, Inc. Announces Pricing of $16 Million Public Offering

By BusinessWire

PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (Nasdaq: ADXS) (the “Company”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of…

July 23, 2019 Off

Global Alopecia Treatment (Hair Loss) Market Growth, Trends, and Forecasts Research Report 2019-2024 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Alopecia Treatment (Hair Loss) Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to…

July 23, 2019 Off

Platelet BioGenesis Signs Lease for New Headquarters in Watertown, Mass.

By BusinessWire

Rapidly growing biotech will relocate to new lab and office space in early 2020 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Platelet BioGenesis, Inc. (PBG),…

July 23, 2019 Off

Banner Life Sciences Announces First Subject Enrolled in Randomized, Double-Blind Head-to-Head Study of BAFIERTAM and Tecfidera for Comparative Assessment of GI Tolerability

By BusinessWire

— Data expected by end of 2019 — HIGH POINT, N.C.–(BUSINESS WIRE)–Banner Life Sciences LLC (Banner), a privately held specialty…

July 23, 2019 Off

IVERIC bio Announces Successful Advancement of LCA10 Minigene Program and Expansion of Orphan Gene Therapy Portfolio with USH2A-Related Inherited Retinal Diseases Program

By BusinessWire

NEW YORK–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) today announced that the Company has exercised its option and entered into an…

July 23, 2019 Off

IQVIA Awarded Frost & Sullivan’s Life Sciences Product Leadership Award for Its Advanced Quality Management Technology Solution

By BusinessWire

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA™ (NYSE:IQV) today announced it has received the Frost & Sullivan’s 2018 Global…

July 23, 2019 Off

PolyActiva Completes Recruitment in Key Phase I Glaucoma Implant Safety Study. Six-month Treatment Period Demonstrated.

By BusinessWire

Company receives additional AU$10m to continue clinical development of biodegradable eye implant CHICAGO–(BUSINESS WIRE)–PolyActiva Pty Ltd, a clinical-stage biotechnology company…

July 23, 2019 Off

Frequency Therapeutics Completes $62 Million Series C Financing

By BusinessWire

Company will use proceeds to advance potential first-in-class drug candidate for hearing restoration and discovery programs using its Progenitor Cell…

July 23, 2019 Off

Dr. Reddy’s Laboratories Announces the Launch of Ramelteon Tablets, in the U.S. Market

By BusinessWire

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together…